Vivos Inc Obtains Feedback from the FDA on Clinical Testing of RadioGel(TM)

Stock Information for Vivos Inc

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Vivos Inc

Radiogel(TM) Precision Radionuclide Therapy(TM) Receives FDA Breakthrough Device Designation
Vivos Inc. Announces Certification of Three New IsoPet® Precision Radionuclide Therapy Regional Clinics
Vivos Inc Files a New Patent on Alternate Particles for Precision Radionuclide Therapy
Vivos Inc Files a New Patent on Precision Radionuclide Therapy Support System Equipment
Vivos Inc Files a New Patent on the Hydrogel Component of IsoPet®/RadioGel(TM)
Vivos Inc. Announces a New IsoPet® Precision Radionuclide Therapy Regional Clinic for Equine Therapy
Vivos Inc. Provides Intellectual Property Protection Update
Vivos Inc Implements Multiple Patient IsoPet® Therapy Day

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.